Carneiro Inês, Timóteo M Alexandrina, Silva Isabel, Vieira Cátia, Baldaia Catarina, Ferreirinha Fátima, Silva-Ramos Miguel, Correia-de-Sá Paulo
Laboratório de Farmacologia e Neurobiologia/UMIB, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto (ICBAS-UP), Portugal.
Br J Pharmacol. 2014 Jul;171(14):3404-19. doi: 10.1111/bph.12711.
Despite the abundant expression of the UDP-sensitive P2Y6 receptor in urothelial cells and sub-urothelial myofibroblasts its role in the control of bladder function is not well understood.
We compared the effects of UDP and of the selective P2Y6 receptor agonist, PSB0474, on bladder urodynamics in anaesthetized rats; the voided fluid was tested for ATP bioluminescence. The isolated urinary bladder was used for in vitro myographic recordings and [(3) H]-ACh overflow experiments.
Instillation of UDP or PSB0474 into the bladder increased the voiding frequency (VF) without affecting the amplitude (A) and the duration (Δt) of bladder contractions; an effect blocked by the P2Y6 receptor antagonist, MRS2578. Effects mediated by urothelial P2Y6 receptors required extrinsic neuronal circuitry as they were not detected in the isolated bladder. UDP-induced bladder hyperactvity was also prevented by blocking P2X3 and P2Y1 receptors, respectively, with A317491 and MRS2179 applied i.v.. UDP decreased [(3) H]-ACh release from stimulated bladder strips with urothelium, but not in its absence. Inhibitory effects of UDP were converted into facilitation by the P2Y1 receptor antagonist, MRS2179. The P2Y6 receptor agonist increased threefold ATP levels in the voided fluid.
Activation of P2Y6 receptors increased the voiding frequency indirectly by releasing ATP from the urothelium and activation of P2X3 receptors on sub-urothelial nerve afferents. Bladder hyperactivity may be partly reversed following ATP hydrolysis to ADP by E-NTPDases, thereby decreasing ACh release from cholinergic nerves expressing P2Y1 receptors.
尽管尿苷二磷酸(UDP)敏感的P2Y6受体在尿路上皮细胞和尿道下肌成纤维细胞中大量表达,但其在膀胱功能控制中的作用尚未完全明确。
我们比较了UDP和选择性P2Y6受体激动剂PSB0474对麻醉大鼠膀胱尿动力学的影响;对排出的尿液进行ATP生物发光检测。分离的膀胱用于体外肌电图记录和[³H]-乙酰胆碱(ACh)溢出实验。
向膀胱内注入UDP或PSB0474可增加排尿频率(VF),而不影响膀胱收缩的幅度(A)和持续时间(Δt);该效应被P2Y6受体拮抗剂MRS2578阻断。尿路上皮P2Y6受体介导的效应需要外在神经回路,因为在分离的膀胱中未检测到该效应。分别静脉注射A317491和MRS2179阻断P2X3和P2Y1受体也可预防UDP诱导的膀胱活动亢进。UDP可降低有尿路上皮的受刺激膀胱条带中[³H]-ACh的释放,但在无尿路上皮时则无此作用。UDP的抑制作用被P2Y1受体拮抗剂MRS2179转化为促进作用。P2Y6受体激动剂可使排出尿液中的ATP水平增加三倍。
P2Y6受体的激活通过从尿路上皮释放ATP并激活尿道下神经传入纤维上的P2X3受体间接增加排尿频率。ATP被外核苷酸焦磷酸酶水解为二磷酸腺苷(ADP)后,膀胱活动亢进可能会部分逆转,从而减少从表达P2Y1受体的胆碱能神经释放ACh。